Neil P Johnson

No ORCID on file · 46 papers in corpus · active 2001-2026

Study types

  • article 30
  • review 7
  • other 4
  • letter 3
  • preprint 1

Condition tags

  • endometriosis 40
  • mesh:D004715 27
  • infertility 13
  • dysmenorrhea 6
  • mesh:D017699 6
  • mesh:D004412 5
  • endometrioma 3
  • dyspareunia 2
  • mesh:D004414 2
  • thoracic_endometriosis 1
article 2026
·doi:10.1142/s2661318226750010
article 2024
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2024.02.004

This group was formed out of the conviction that endometriosis research has not progressed at a pace in proportion to disease severity and the negative impact on women's quality of life. Furthermore, advancement in our understanding of this…

letter 2024
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2024.04.008
article 2024
Human Reproduction ·doi:10.1093/humrep/dead263

STUDY QUESTION: What is the efficacy and safety of long-term treatment (up to 2 years) with relugolix combination therapy (CT) in women with moderate to severe endometriosis-associated pain? SUMMARY ANSWER: For up to 2 years, treatment with…

article 2023
Pain management ·doi:10.2217/pmt-2023-0052

WHAT IS THIS SUMMARY ABOUT?: This is a summary of research studies (known as clinical trials) called SPIRIT 1 and SPIRIT 2. The SPIRIT 1 and SPIRIT 2 studies compared how well a medicine called relugolix combination therapy worked in reliev…

article 2023
·doi:10.1097/01.aog.0000929844.43483.20

INTRODUCTION: Relugolix combination therapy (Relugolix-CT: relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) significantly improved endometriosis-associated pain versus placebo in the SPIRIT 1&2 studies. Efficacy was maintained…

article 2023
·doi:10.1016/j.fertnstert.2023.08.234
article 2022
Human reproduction open ·doi:10.1093/hropen/hoac002

STUDY QUESTION: Which classification system for endometriosis do clinicians use most frequently, and why? SUMMARY ANSWER: Even with a high uptake of the three existing endometriosis classification systems, most clinicians managing endometri…

review 2022
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2022.01.014
article 2022
·doi:10.1016/j.fertnstert.2022.08.631
article 2022
Lancet (London, England) ·doi:10.1016/s0140-6736(22)00622-5

BACKGROUND: Endometriosis is a common cause of pelvic pain in women, for which current treatment options are suboptimal. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, combined with estradiol and a progestin, was eva…

article 2022
·doi:10.1016/j.fertnstert.2022.08.035
article 2021
Human reproduction open ·doi:10.1093/hropen/hoab029

STUDY QUESTION: Can a set of terms and definitions be prepared on endometriosis that would be the basis for standardization in disease description, classification and research? SUMMARY ANSWER: The current paper outlines a list of 49 terms a…

review 2021
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2021.08.032

OBJECTIVE: Different classification systems have been developed for endometriosis, using different definitions for the disease, the different subtypes, symptoms and treatments. In addition, an International Glossary on Infertility and Ferti…

article 2021
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.13322

BACKGROUND: Endometriosis-specific (advanced gynaecological) ultrasound is recommended as part of preoperative work-up of women with suspected endometriosis. AIM: To evaluate the awareness and utilisation of advanced gynaecological ultrasou…

review 2021
Human reproduction open ·doi:10.1093/hropen/hoab025

STUDY QUESTION: Which endometriosis classification, staging and reporting systems have been published and validated for use in clinical practice? SUMMARY ANSWER: Of the 22 endometriosis classification, staging and reporting systems identifi…

review 2021
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2021.07.023

OBJECTIVE: In the field of endometriosis, several classification, staging and reporting systems have been developed. Which endometriosis classification, staging and reporting systems have been published and validated for use in clinical pra…

article 2021
·doi:10.1016/j.fertnstert.2021.07.144
other 2021
Human Reproduction ·doi:10.1093/humrep/deaa312

Iodine is a vital micronutrient and its importance in thyroid function is well established. However, abnormalities in iodine intake may also have other effects. In particular, iodine is taken up avidly by the ovary and endometrium. Iodine d…

article 2020
Frontiers in reproductive health ·doi:10.3389/frph.2020.00005

COVID-19 has led to new obstacles in the care for women with endometriosis. With many centers around the globe temporarily ceasing outpatient appointments, diagnostic imaging for non-acute pelvic pain, surgery for endometriosis, and fertili…

article 2020
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC ·doi:10.1016/j.jogc.2019.12.014
article 2020
Human reproduction open ·doi:10.1093/hropen/hoaa028

The care of patients with endometriosis has been complicated by the coronavirus disease 2019 (COVID-19) pandemic. Medical and allied healthcare appointments and surgeries are being temporarily postponed. Mandatory self-isolation has created…

review 2019
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2019.10.014
article 2018
Obstetrics and gynecology ·doi:10.1097/aog.0000000000002675

OBJECTIVE: To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain. METHODS: Elaris Endometriosis (EM)-III and -IV were exten…

article 2018
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2018.11.015